HomeInsightsResults

Aspira Pathlab & Diagnostics Ltd Quarterly Result

Aspira Pathlab & Diagnostics Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

Net Profit

₹ 0.99

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Aspira Pathlab & Diagnostics Ltd for the Sep '24 is ₹ 6.25 crore as compare to the Jun '24 revenue of ₹ 4.79 crore. This represent the growth of 30.480167%.
  • The ebitda of Aspira Pathlab & Diagnostics Ltd for the Sep '24 is ₹ 1.35 crore as compare to the Jun '24 ebitda of ₹ 0.42 crore. This represent the growth of 221.4286%.
  • The net profit of Aspira Pathlab & Diagnostics Ltd for the Sep '24 is ₹ 0.99 crore as compare to the Jun '24 net profit of ₹ 0.05 crore. This represent the growth of 1880%.

Results Analysis

Market Price of Aspira Pathlab & Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202466
21 Nov 202464.3
19 Nov 202467.68
18 Nov 202469.9
14 Nov 202466.58
13 Nov 202463.41
12 Nov 202461
11 Nov 202461.75
08 Nov 202459.82
07 Nov 202456.98

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical EBITDA of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Aspira Pathlab & Diagnostics Ltd News Hub

News

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

30 Oct 202416:55

News

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the compan...

Read more

28 Aug 202412:02

News

Aspira Pathlab & Diagnostics to announce Quarterly Result

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

05 Aug 202414:32

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

21 May 202412:07

News

Aspira Pathlab & Diagnostics revises board meeting date

Aspira Pathlab & Diagnostics has revised the meeting of the Board of Directors which was s...

Read more

06 Feb 202412:39

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

02 Feb 202415:34

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Aspira Pathlab Diagnostics Ltd Quarterly Result

What is the EPS of Aspira Pathlab & Diagnostics Ltd stock?

The Earnings Per Share (EPS) of Aspira Pathlab & Diagnostics Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Aspira Pathlab & Diagnostics Ltd EPS calculated?

The EPS of Aspira Pathlab & Diagnostics Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aspira Pathlab & Diagnostics Ltd report its EPS?

Aspira Pathlab & Diagnostics Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aspira Pathlab & Diagnostics Ltd EPS?

Factors that influence the EPS of Aspira Pathlab & Diagnostics Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aspira Pathlab & Diagnostics Ltd EPS growth indicate future performance?

Yes, consistent growth in Aspira Pathlab & Diagnostics Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*